Filters
How Much Does Castleman Disease Treatment Cost in South Korea?
The cost of Castleman Disease Treatment in South Korea typically ranges between USD 4000 - USD 6000. It's important to note that these are approximate costs and can vary based on the hospital, location, and individual patient needs. Additionally, factors like the duration of treatment, the need for follow-up care, and the use of advanced technologies or specialized treatments can further influence the overall cost.
Factors Influencing the Cost of Castleman Disease Treatment in South Korea
- Patient's Health Condition: The patient's overall health and any underlying medical conditions can significantly influence the cost of treatment. Those with more complex health issues may require additional care and resources.
- Type of Castleman Disease: Treatment costs can vary depending on whether the patient has Unicentric Castleman Disease (UCD) or Multicentric Castleman Disease (MCD). MCD generally requires more extensive treatment and ongoing management.
- Treatment Approach: The choice of treatment, such as surgery, medication, or a combination of therapies, can impact the overall cost. For example, the use of specific medications like siltuximab can be more expensive.
- Hospital and Location: Treatment costs can differ based on the hospital and its geographical location. Hospitals in metropolitan areas generally charge higher fees compared to those in smaller towns or rural regions. Additionally, hospitals equipped with advanced facilities and specialized expertise tend to have higher costs
- Duration of Hospital Stay: The length of the hospital stay required for treatment and recovery can affect the total cost. Longer stays typically result in higher expenses.
- Surgeon's Experience: The expertise and experience of the physicians can impact the cost. Highly experienced surgeons may charge more for their services.
Cost of Castleman Disease Treatment in Major Cities of South Korea
| City | Minimum Cost (USD) | Minimum Cost (KRW) | Maximum Cost (USD) | Maximum Cost (KRW) |
|---|---|---|---|---|
| Seoul | USD 4000 | 5503920 | USD 6000 | 8255880 |
Castleman Disease Treatment Cost : A Global Comparison
| Country | Minimum Cost | Minimum Local Currency | Maximum Cost | Maximum Local Currency |
|---|---|---|---|---|
| Czechia | get request | |||
| India | get request | |||
| Israel | get request | |||
| Malaysia | USD 2261 | MYR 9587 | USD 11305 | MYR 47933 |
| Poland | USD 3800 | PLN 14288 | USD 5500 | PLN 20680 |
| Saudi Arabia | get request | |||
| Singapore | - | - | USD 5400 | SGD 6966 |
| South Korea | USD 4000 | KRW 5503920 | USD 6000 | KRW 8255880 |
| Spain | USD 11000 | ESP 1617439 | USD 44000 | ESP 6469756 |
| Switzerland | get request | |||
| Thailand | get request | |||
| Turkey | get request | |||
| United Arab Emirates | USD 3150 | AED 11560 | USD 3850 | AED 14130 |
| United Kingdom | get request | |||
Need Help Planning Your Treatment Abroad?
Your 24/7 AI Health Assistant 
Castleman disease is a group of rare disorders characterized by enlarged lymph nodes and a wide range of symptoms. The most common form of the disorder involves a single enlarged lymph node, typically found in the chest or neck, but it can occur in other areas of the body as well. This form is known as Unicentric Castleman Disease (UCD).
Multicentric Castleman Disease (MCD), on the other hand, involves multiple regions of enlarged lymph nodes, along with inflammatory symptoms and problems with organ function.
The goals of treating Castleman's illness are to reduce inflammation, alleviate symptoms, control aberrant lymph node cell growth, and avoid significant side effects, including cancer or infections. Whether the disease is widespread (Multicentric Castleman Disease, or MCD) or limited (Unicentric Castleman Disease, or UCD), the objective is to control it and enhance quality of life.
Consult a physician if you have fever, night sweats, enlarged organs, unexplained weight loss, swollen lymph nodes, or chronic exhaustion. MediGence's team of professionals can help you get an accurate diagnosis and a condition-specific care plan.
Preparation includes blood testing, imaging (CT, PET, or MRI scans), and lymph node biopsy to determine the disease subtype (ucd, HHV-8-associated MCD, or idiopathic MCD). Consult your doctor about all of your current medications and medical history. In multicentric instances, further HIV and HHV-8 screening might be necessary.
- Surgical Removal: The afflicted lymph node is usually removed during surgery for UCD.
- Medications: Corticosteroids, immunotherapy, antiviral medications (if HHV-8 positive), or chemotherapy are some of the medicines used to treat MCD.
- Supportive Care: Monitoring organ function, preventing infections, and managing discomfort are all included in supportive care.
- Follow-up: Continuous assessment using imaging and labs to evaluate response and modify therapy.
Surgical removal in UCD may require a brief hospital stay and a few weeks of recovery. Treatment for MCD involves continuous medication or therapy for several months under close observation. The length of treatment varies according to the severity and response of the disease.
There are no known risk factors for Unicentric Castleman Disease (UCD) or Idiopathic Multicentric Castleman Disease (iMCD), but individuals with HIV or weakened immune systems are at higher risk for Human Herpesvirus 8 (HHV-8) associated Multicentric Castleman Disease (MCD). In rare instances, Castleman disease can result in paraneoplastic pemphigus (PNP) in UCD patients and raise the risk of malignancies like lymphoma. Additionally, MCD may increase the risk of serious infections, which, if left untreated, can result in potentially fatal organ damage.
With timely and focused treatment, effective symptom management, lymph node reduction, prevention of complications, and general quality of life can all be achieved. While continuous therapy aids in maintaining disease control and stability in MCD, surgery frequently leads to a full recovery in Unicentric Castleman Disease.
Following UCD surgery, recovery includes wound care and pain management, along with follow-up to make sure there is no recurrence. Patients with MCD may require ongoing care and routine monitoring for immune system activity, infections, and medication response.
Surgical treatment for UCD has a high success rate and is often curative. Modern treatments for MCD, such as monoclonal antibodies, have greatly enhanced results and provided efficient long-term disease management.
Would you like some help? We are available.
Get Help Explore Hospitals ( 2 )
Asan Medical Centre
Seoul, South Korea
Asan Medical Centre located in Seoul, South Korea is accredited by ISO. Also listed below are some of the most prominent infrastructural details:
- 524,700 square meters is the floor area of Asan Medical Centre
- Number of beds is 2,715
- 67 operating rooms
- 11,680 outpatients
- Everday 2,427 inpatients come to the Centre
- 66,838 Sophisticated surgeries (per year)
- 1,600 physicians and surgeons
- 3,100 nurses
- Five various types of rooms ranging from suites to multi-bed rooms
International St. Mary's Hospital
Seoul, South Korea
International St. Mary's Hospital located in Seoul, South Korea is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
- 3 Basements and 5 Floors Building
- International Healthcare Center
- Korean Traditional Medicine Hospital
- Hybrid Operation Theatres
- Conference Rooms
- Seminar Rooms
- Auditorium
- Intensive Care Units
- Hospice ward
- Chapel
- Emergency Medical Center
- Pathology
- Outpatient Pharmacy
- 15 Professional Treatment Centers
- 35 Clinical Departments
- Transplant Centers
- Admission & Discharge Center
- Counseling office
- Convenience Store
- Animal Laboratories
- Parking in basement
- Food court for patients & visitors
- Coffee Shop
- Free Wi-fi is available throughout the Hospital premises
Need Some Advice From Our Experts?
Request a Call Back Now!
Our team of healthcare experts would be happy to assist you
+99Process Involved for Castleman Disease Treatment in South Korea
Diagnosis and Evaluation
- Medical History and Physical Exam: Review of patient's medical history and physical examination.
- Blood and Urine Tests: Identifies anemia and changes in blood proteins.
- Imaging Tests: CT scans, MRI, and PET scans locate enlarged lymph nodes or organs.
- Lymph Node Biopsy: Confirms diagnosis by examining a tissue sample.
Treatment Planning
- Consultation with Specialists: Development of a comprehensive treatment plan.
- Discussion of Treatment Options: Evaluation of surgery, medication, and radiation therapy along with potential risks and benefits.
Treatment Implementation
- Unicentric Castleman Disease (UCD):
- Surgery: Removal of affected lymph node, usually curative.
- Medication: Alternative if surgery isn't possible.
- Radiation Therapy: Option if surgery and medications are ineffective.
- Multicentric Castleman Disease (MCD):
- HHV-8-positive MCD: Rituximab (Rituxan) is highly effective; may include antiviral medications and chemotherapies.
- Idiopathic MCD: Siltuximab (Sylvant) blocks interleukin-6; corticosteroids and chemotherapy may also be used.
- Castleman Disease
Patients who are suffering from Castleman Disease.
- Bone Marrow Biopsy: This procedure may be performed to assess bone marrow involvement and guide treatment decisions.
- Plasmapheresis: A procedure to remove excess antibodies from the blood, helping to manage symptoms and improve the patient's condition.
- Intravenous Immunoglobulin (IVIG) Therapy: Involves infusing antibodies into the bloodstream to boost the immune system and manage symptoms.
- Symptom Relief: Effective treatment can alleviate symptoms such as fever, night sweats, fatigue, and enlarged lymph nodes, improving the patient's overall quality of life.
- Disease Control: Treatment can help control the overgrowth of lymphatic cells, preventing the disease from progressing and reducing the risk of complications.
- Improved Organ Function: For patients with Multicentric Castleman Disease (MCD), treatment can enhance the function of affected organs, such as the liver and spleen.
- Reduced Risk of Infections: By managing the disease and its symptoms, treatment can help reduce the risk of infections, which are more common in patients with weakened immune systems.
- Enhanced Longevity: Timely and effective treatment can improve the patient's prognosis and increase their chances of long-term survival.
- Better Quality of Life: Overall, successful treatment can lead to a better quality of life, allowing patients to resume their daily activities and enjoy a more normal lifestyle.
- Oncologist
- Hematologist
- Radiation Oncologist
- Fill out the inquiry form: Fill out the form to provide us with the relevant information about your condition.
- Consult with Our Healthcare Expert: One of our qualified specialists will contact you for a consultation.
- Receive a Detailed Treatment Plan: After examining your situation, we will provide you with a detailed treatment plan that includes expert views and cost breakdowns for various choices.
- Choose your preferred option: Choose the therapy option that best suits you.
- Seamless Organization: We will manage all the details, including visas, flights, accommodations, and transfers, for a stress-free journey.
